Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization

This study is testing whether a supplement derived from a medicinal mushroom — Antrodia cinnamomea — can reduce side effects and improve recovery in people with liver cancer (hepatoma) who are receiving a procedure called TACE (transcatheter arterial chemoembolization), which delivers chemotherapy directly into the liver tumor through a catheter. **You may be eligible if...** - You are between 20 and 80 years old - You have a Child-Pugh liver function score of Class A or B (meaning your liver is functioning reasonably well) - Your liver enzyme levels (ALT, AST, bilirubin) are within acceptable ranges - You have signed the informed consent form **You may NOT be eligible if...** - You have a Child-Pugh Class C score (severely impaired liver function) - You have a blood clot blocking the main portal vein - Your liver cancer is diffuse (spread throughout the liver) - You have an allergy to contrast dye used during the procedure - You have abnormal blood clotting function Talk to your doctor to see if this trial is right for you.